Keywords: Strides Arcolab,, Ascent Pharmahealth, M&D, Australasia
Strides Arcolab raises offer for Ascent's remaining shares to $0.40
Article | 24 December 2010
Bangalore, India-based drugmaker Strides Arcolab (BSE: 532531) says it has raised its offer price for acquiring 43% minority share in Australia-based Ascent ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
